Discussions with Mr. Aluminum

By Christopher Exley, PhD, FRSB

Review

If you think reading about aluminum would be boring, guess again! Professor Exley is a gifted teacher and presents the subject matter in a very readable form. He explains in simple, understandable terms, the science of the effects of aluminum on the human body. He discusses aluminum in human health as a personal experience that you can control. 

The book contains details of aluminum in our food, drink, cosmetics, medicines and how it contributes to Cancer, Alzheimer’s disease, and Autism, Multiple Scleroses, Parkinson’s disease and more. This book is more than informative; it is a reference book for everyone who might want scientific references on the subject.

“All of the aluminum found in, or associated with, the human body has the potential to result in toxicity.”

“…biologically reactive aluminum will be in the right place at the right time in sufficient quantity to manifest toxicity in the body. Aluminum is only toxic; it really should not be in the body.”

“By identifying Al3+ as the perpetrator of toxicity, all other forms of aluminum can be considered as sources of Al3+. All forms of aluminum including metallic forms will break down under certain conditions to release Al3+ for binding molecules.”

When aluminum enters the human body, by ingesting it in food or drink, or rubbing it in our skin from antiperspirants or sunscreen, it becomes biologically reactive. Aluminum has no purpose in our body; it has no benefit to us. Once aluminum comes into the body it has to go somewhere. Where? Your cells take it and park it in soft tissue or bone. It gets taken to the brain and organ tissues and it causes trouble. Professor Exley explains how you can help eliminate some of this aluminum on a daily basis. It is as easy as drinking water, but not any kind of water.

 The chapter on vaccine safety is a must read. “There is no requirement of vaccine manufacturers to demonstrate that aluminum adjuvants, the most critical component of this type of vaccine, are safe for use in humans. Consequently, there are no safety studies, and there are no aluminum adjuvants approved for use in human vaccines.”

This is a must read book for anyone concerned about the causes of major diseases in themselves or their loved ones and children.

Cancer Corner USA
Eileen Sellers

 

Tel: 01782 734080
Fax: 01782 712378
e-mail: c.exley@keele.ac.uk
http://www.keele.ac.uk/aluminium

June 15, 2017

United States Department of Health & Human Services
National Institutes of Health
Food & Drug Administration
Centers for Disease Control & Prevention
200 Independence Avenue, S.W.
Washington, D.C. 20201

Re: Aluminum Adjuvants

Dear Directors:
I am an expert in the field of aluminum adjuvants and aluminum toxicity. I have been
working in this field for more than 30 years during which time I have written in excess of 150
peer-reviewed scientific publications on this subject.

I strongly support the contention that aluminum adjuvants in vaccines may have a role
in the etiology of autism spectrum disorder (ASD). My view is founded on a significant and
burgeoning body of peer-reviewed scientific evidence which makes the link between ASD
and exposure to aluminum through vaccinations and other sources. Examples of this literature from my own group are detailed below and I urge the HHS to take them into consideration in forming any future opinion on the safety of aluminum adjuvants in vaccines.

The Center for Disease Control’s claim on its website that “Vaccines Do Not Cause
Autism” is unsupported with respect to aluminum adjuvants and this claim stifles the
important research to determine the safety of aluminum adjuvants used in vaccines. As an
expert in the field of aluminum adjuvants and aluminum toxicity I solemnly declare that more research on the role of aluminum adjuvant in vaccines and neurological disorders, including ASD, is essential and urgently required.

Telephone number +44 (01782) 584211
Fax +44 (01782) 712378
Keele University, Staffordshire, ST5 5BG United Kingdom
Telephone number +44 (01782) 621111 http://www.keele.ac.uk

Yours faithfully

Christopher Exley PhD
Professor in Bioinorganic Chemistry

Honorary Professor, University of the Highlands and Islands

List of Recent, Relevant and Significant Publications From Our Group

Exley C, Siesjö P & Eriksson H (2010) The immunobiology of aluminium adjuvants: how do they really work?
Trends in Immunology 31, 103-109.

Exley C and House E (2011) Aluminium in the human brain. Monatshefte für Chemie – Chemical Monthly 142, 357-363.

House E, Esiri M, Forster G, Ince PG and Exley C (2012) Aluminium, iron and copper in human brain tissues donated to the medical research council’s cognitive function and ageing study. Metallomics 4, 56-65.

Exley C (2011) Aluminium-based adjuvants should not be used as placebos in clinical trials. Vaccine 29, 9289.

Exley C (2012) When an aluminium adjuvant is not an aluminium adjuvant used in human vaccination programmes. Vaccine 30, 2042.

Exley C (2012) The coordination chemistry of aluminium in neurodegenerative disease. Coordination Chemistry Reviews 256, 2142-2146.

Exley C, House E, Polwart A and Esiri MM (2012) Brain burdens of aluminium, iron and copper and their relationships with amyloid beta pathology in 60 human brains. Journal of Alzheimer’s Disease 31, 725-730.

Davenward S, Bentham P, Wright J, Crome P, Job, D, Polwart A and Exley C (2013) Silicon-rich mineral water as a non-invasive test of the ‘aluminium hypothesis’ in Alzheimer’s disease. Journal of Alzheimer’s Disease 33, 423-430.

Khan Z, Combadière C, Authier FJ, Itier V, Lux F, Exley C, Mahrouf-Yorgov M, Decrouy X, Moretto P, Tillement O, Gherardi RK, and Cadusseau J (2013) Slow CCL2-dependent translocation of biopersistent particles from muscle to brain. BMC Medicine 11:99.

Exley C (2013) Human exposure to aluminium. Environmental Science:Processes and Impacts 15, 1807-1816.

Ohlsson L, Exley C, Darabi A, Sandén E, Siesjö P and Eriksson H (2013) Aluminium based adjuvants and their effects on mitochondria and lysosomes of phagocytosing cells. Journal of Inorganic Biochemistry 128, 229-236.

Exley C (2014) Aluminium adjuvants and adverse events in sub-cutaneous allergy immunotherapy. Allergy, Asthma and Clinical Immunology 10, 4.

Exley C and Vickers T (2014) Elevated brain aluminium and early onset Alzheimer’s disease in an individual occupationally exposed to aluminium: a case report. Journal of Medical Case Reports 8,41.

Exley C (2014) What is the risk of aluminium as a neurotoxin? Expert Review of Neurotherapeutics 14, 589-591.

Mold M, Eriksson H, Siesjö P, Darabi A, Shardlow E and Exley C (2014) Unequivocal identification of intracellular aluminium adjuvant in a monocytic THP-1 cell line. Scientific Reports 4, 6287.

Telephone number +44 (01782) 584211
Fax +44 (01782) 712378
Keele University, Staffordshire, ST5 5BG United Kingdom
Telephone number +44 (01782) 621111 http://www.keele.ac.uk

Exley C (2014) Why industry propaganda and political interference cannot disguise the inevitable role played by human exposure to aluminium in neurodegenerative diseases, including Alzheimer’s disease. Frontiers in Neurology 5:212. doi: 10.3389/fneur.2014.00212.

Crépeaux G, Eidi H, David M-O, Tzavara E, Giros B, Exley C, Curmi PA, Shaw CA, Gherardi RK and Cadusseau J (2015) Highly delayed systemic translocation of aluminium-based adjuvant in CD1 mice following intramuscular injections. Journal of Inorganic Biochemistry 152, 199-205.

Exley C (2016) The toxicity of aluminium in humans. Morphologie 100, 51-55.

Mirza A, King A, Troakes C and Exley C (2016) The identification of aluminium in human brain tissue using lumogallion and fluorescence microscopy. Journal of Alzheimer’s Disease 54, 1333-1338.

Mold M, Shardlow E and Exley C (2016) Insight into the cellular fate and toxicity of aluminium adjuvants used in clinically-approved human vaccinations. Scientific Reports 6:31578.

Mirza A, King A, Troakes C and Exley C (2017) Aluminium in brain tissue in familial Alzheimer’s disease. Journal of Trace Elements in Medicine and Biology 40, 30-36.

Shardlow E, Mold M and Exley C (2017) From stock bottle to vaccine: Elucidating the particle size distributions of aluminium adjuvants using dynamic light scattering. Frontiers in Chemistry 4, 48.

Exley C (2017) Aluminium should now be considered a primary aetiological factor in Alzheimer’s disease. Journal of Alzheimer’s Disease Reports 1, 23-25.

Telephone number +44 (01782) 584211
Fax +44 (01782) 712378
Keele University, Staffordshire, ST5 5BG United Kingdom
Telephone number +44 (01782) 621111 http://www.keele.ac.uk